清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Abstract 1189: Modulation of the MSS and MSI colorectal cancer immune microenvironment with FOLFOX and FOLFIRI -/+ anti-PD-1 immunotherapy

福尔菲里 福克斯 结直肠癌 医学 免疫疗法 肿瘤微环境 肿瘤科 免疫系统 内科学 癌症 癌症研究 免疫学 奥沙利铂
作者
Lindsey Carlsen,Maximilian P. Pinho-Schwermann,Leiqing Zhang,Andrew Elliott,Kelsey E. Huntington,William MacDonald,Brooke Verschleiser,Laura Jinxuan Wu,Wafik S. El‐Deiry
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 1189-1189 被引量:1
标识
DOI:10.1158/1538-7445.am2024-1189
摘要

Abstract Metastatic colorectal cancer (mCRC) is a deadly disease with a five-year survival rate of 14%. Most patients receive 5-FU (F) and folinic acid (FOL) combined with oxaliplatin (OX), irinotecan (IRI), or both (OXIRI). Immune checkpoint inhibitors (ICIs) are effective against microsatellite instable (MSI) tumors, but 95% of mCRC tumors are microsatellite stable (MSS) and ICI-resistant. Though the primary targets of 5-FU, irinotecan, and oxaliplatin are well-understood, their effects on the tumor microenvironment (TME) remain incompletely characterized. Chemotherapy-mediated immune stimulation in MSS CRC has been observed in preclinical models and clinical trials. We hypothesize that combination chemotherapy treatment modulates the immune microenvironment of CRC -/+ ICI, with differences across subtype and treatment regimen. Chemotherapy-dependent changes in cancer cell gene expression, PD-L1 levels, cytokine secretion, and T cell activation were measured using in vitro models of MSS and MSI CRC. A preliminary evaluation of spleen and tumor T cells and dendritic cells (DCs) in murine models of MSS and MSI CRC after immunotherapy -/+ chemotherapy was conducted. CD8+ T cells, DCs, PD-L1, CD69, and GM-CSF expression were measured in clinical specimens of chemotherapy-treated MSS mCRC patients. In MSS CRC, FOX increased GM-CSF and activated CD8+ T cells in vitro and activated splenic CD8+ and CD4+ T cells in vivo. FOX and FIRI suppressed an anti-PD-1-mediated enhancement of type 1 cDCs in the tumor in vivo. FOLFOX was associated with increased tumor CD8+ T cells and decreased GM-CSF in MSS mCRC biopsies. FIRI treatment increased PD-L1 in vitro. FOLFIRI was not associated with increased tumor CD8+ T cells in MSS mCRC biopsies. In MSI CRC, FOX increased tumor CD8+ T cells in vivo. Here, we elucidate novel effects of clinically relevant chemotherapy combinations on the TME in MSS and MSI CRC. These data point to a FOX-specific mechanism by which CD8+ T cell infiltration into MSS mCRC tumors is enhanced, but their activation is halted potentially by GM-CSF suppression and/or type 1 cDC depletion in the TME. These findings contribute to our understanding of the mechanisms of chemotherapy-dependent immune modulation and bring the field closer to harnessing these effects for therapeutic gain. Citation Format: Lindsey Carlsen, Maximilian Pinho-Schwermann, Leiqing Zhang, Andrew Elliott, Kelsey E. Huntington, William J. MacDonald, Brooke Verschleiser, Laura Jinxuan Wu, Wafik S. El-Deiry. Modulation of the MSS and MSI colorectal cancer immune microenvironment with FOLFOX and FOLFIRI -/+ anti-PD-1 immunotherapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1189.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ding的应助被amiee采纳,获得10
4秒前
含蓄的新柔完成签到,获得积分10
6秒前
dianeil发布了新的文献求助10
15秒前
25秒前
amiee发布了新的文献求助10
31秒前
somehgo的应助被betsydouglas14采纳,获得30
37秒前
共享精神的应助被ping采纳,获得10
39秒前
包容的初阳完成签到,获得积分10
45秒前
48秒前
激动的忆翠完成签到,获得积分10
53秒前
风趣馒头完成签到,获得积分10
1分钟前
1分钟前
无私的碧玉完成签到,获得积分10
1分钟前
俭朴迎荷完成签到,获得积分10
1分钟前
1分钟前
n01W97的应助被科研通管家采纳,获得70
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
怕黑靖荷完成签到,获得积分10
1分钟前
专一的思菱完成签到,获得积分10
1分钟前
1分钟前
欢呼亦绿完成签到,获得积分10
1分钟前
ping发布了新的文献求助10
1分钟前
文静飞松完成签到,获得积分10
2分钟前
喜悦的紫雪完成签到,获得积分10
2分钟前
故意的白风完成签到,获得积分10
2分钟前
要减肥的菀完成签到,获得积分10
3分钟前
矢思然完成签到,获得积分10
3分钟前
蓝意完成签到,获得积分0
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
cocolinfly完成签到 ,获得积分10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
Maestro_S的应助被科研通管家采纳,获得10
3分钟前
烂漫的诗蕊完成签到,获得积分10
3分钟前
快乐的如曼完成签到 ,获得积分10
3分钟前
淡淡傲柔完成签到,获得积分10
3分钟前
欣慰怀梦完成签到,获得积分10
4分钟前
漂亮忆曼完成签到,获得积分10
4分钟前
不如看海完成签到 ,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185411
求助须知:如何正确求助?哪些是违规求助? 9574140
关于积分的说明 21834375
捐赠科研通 7782865
什么是DOI,文献DOI怎么找? 3434552
关于科研通互助平台的介绍 2558842
邀请新用户注册赠送积分活动 2481280